| pubmed-article:8174549 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8174549 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8174549 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:8174549 | lifeskim:mentions | umls-concept:C0005821 | lld:lifeskim |
| pubmed-article:8174549 | lifeskim:mentions | umls-concept:C0063146 | lld:lifeskim |
| pubmed-article:8174549 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:8174549 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8174549 | pubmed:dateCreated | 1994-6-9 | lld:pubmed |
| pubmed-article:8174549 | pubmed:abstractText | Platelets primed by exposure to subthreshold concentrations of arachidonic acid or collagen are known to be activated by nanomolar levels of hydrogen peroxide. We here demonstrate that this effect is mediated by hydroxyl radicals (OHzero) formed in an extracellular Fenton-like reaction. H2O2-induced platelet aggregation, serotonin release and thromboxane A2 productions were inhibited by OHzero scavengers and by the iron chelator desferrioxamine; hydroxyl radicals were detected directly by ESR measurements of the spin-trapped OHzero adduct. The role of OHzero was confirmed in experiments with exogenously added iron; free or EDTA-bound ferrous iron activated platelets in a process blocked by deoxyribose, mannitol or catalase, whereas ferric iron was without effect unless reductants were included. The activation by OHzero depended on concomitant release of arachidonic acid and was blocked by the phospholipase A2 inhibitors mepacrine and aristolochic acid, and by the Na+/K+ antiporter inhibitor ethylisopropylamiloride. In contrast, neomycin and staurosporin were without effects, indicating that phospholipase C and protein kinase C were not involved in the initial phase of activation. Neither radical formation nor arachidonic acid release was blocked by aspirin. In whole blood aggregation of platelets could be induced by H2O2 generated upon specific stimulation of neutrophils by N-formyl-methionyl-leucyl-phenylalanine; platelet activation and radical formation were blocked by the NADPH oxidase inhibitor diphenyliodonium as well as by catalase and mannitol. These results suggest that reactive oxygen species act as 'second messengers' during the initial phase of the platelet activation process. | lld:pubmed |
| pubmed-article:8174549 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8174549 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8174549 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8174549 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8174549 | pubmed:issn | 0014-2956 | lld:pubmed |
| pubmed-article:8174549 | pubmed:author | pubmed-author:RotilioGG | lld:pubmed |
| pubmed-article:8174549 | pubmed:author | pubmed-author:VioliFF | lld:pubmed |
| pubmed-article:8174549 | pubmed:author | pubmed-author:PedersenJ ZJZ | lld:pubmed |
| pubmed-article:8174549 | pubmed:author | pubmed-author:IulianoLL | lld:pubmed |
| pubmed-article:8174549 | pubmed:author | pubmed-author:PraticòDD | lld:pubmed |
| pubmed-article:8174549 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8174549 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8174549 | pubmed:volume | 221 | lld:pubmed |
| pubmed-article:8174549 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8174549 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8174549 | pubmed:pagination | 695-704 | lld:pubmed |
| pubmed-article:8174549 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:meshHeading | pubmed-meshheading:8174549-... | lld:pubmed |
| pubmed-article:8174549 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8174549 | pubmed:articleTitle | Role of hydroxyl radicals in the activation of human platelets. | lld:pubmed |
| pubmed-article:8174549 | pubmed:affiliation | Institute of 1st Clinical Medicine, University La Sapienza, Rome, Italy. | lld:pubmed |
| pubmed-article:8174549 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8174549 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8174549 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8174549 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8174549 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8174549 | lld:pubmed |
